Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

NCT06575127 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Neoplasm Malignant
Colon Cancer Stage 4

Interventions

DRUG: FOLFOXIRI Protocol

Sponsor

Al-Azhar University